261 related articles for article (PubMed ID: 15939810)
1. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
Fiebeler A; Nussberger J; Shagdarsuren E; Rong S; Hilfenhaus G; Al-Saadi N; Dechend R; Wellner M; Meiners S; Maser-Gluth C; Jeng AY; Webb RL; Luft FC; Muller DN
Circulation; 2005 Jun; 111(23):3087-94. PubMed ID: 15939810
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes.
Mervaala E; Müller DN; Park JK; Dechend R; Schmidt F; Fiebeler A; Bieringer M; Breu V; Ganten D; Haller H; Luft FC
Hypertension; 2000 Jan; 35(1 Pt 2):360-6. PubMed ID: 10642325
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
[TBL] [Abstract][Full Text] [Related]
4. Complement activation in angiotensin II-induced organ damage.
Shagdarsuren E; Wellner M; Braesen JH; Park JK; Fiebeler A; Henke N; Dechend R; Gratze P; Luft FC; Muller DN
Circ Res; 2005 Sep; 97(7):716-24. PubMed ID: 16109917
[TBL] [Abstract][Full Text] [Related]
5. Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.
Theuer J; Shagdarsuren E; Muller DN; Kaergel E; Honeck H; Park JK; Fiebeler A; Dechend R; Haller H; Luft FC; Schunck WH
Kidney Int; 2005 Jan; 67(1):248-58. PubMed ID: 15610248
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes.
Biala A; Tauriainen E; Siltanen A; Shi J; Merasto S; Louhelainen M; Martonen E; Finckenberg P; Muller DN; Mervaala E
Blood Press; 2010 Jun; 19(3):196-205. PubMed ID: 20429690
[TBL] [Abstract][Full Text] [Related]
7. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
Park JK; Müller DN; Mervaala EM; Dechend R; Fiebeler A; Schmidt F; Bieringer M; Schäfer O; Lindschau C; Schneider W; Ganten D; Luft FC; Haller H
Kidney Int; 2000 Oct; 58(4):1420-30. PubMed ID: 11012877
[TBL] [Abstract][Full Text] [Related]
8. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
9. Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats.
Pilz B; Shagdarsuren E; Wellner M; Fiebeler A; Dechend R; Gratze P; Meiners S; Feldman DL; Webb RL; Garrelds IM; Jan Danser AH; Luft FC; Müller DN
Hypertension; 2005 Sep; 46(3):569-76. PubMed ID: 16103264
[TBL] [Abstract][Full Text] [Related]
10. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.
Rocha R; Martin-Berger CL; Yang P; Scherrer R; Delyani J; McMahon E
Endocrinology; 2002 Dec; 143(12):4828-36. PubMed ID: 12446610
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-converting enzyme inhibition ameliorates angiotensin II-induced cardiac damage.
Muller DN; Mullally A; Dechend R; Park JK; Fiebeler A; Pilz B; Löffler BM; Blum-Kaelin D; Masur S; Dehmlow H; Aebi JD; Haller H; Luft FC
Hypertension; 2002 Dec; 40(6):840-6. PubMed ID: 12468567
[TBL] [Abstract][Full Text] [Related]
13. Entacapone protects from angiotensin II-induced inflammation and renal injury.
Helkamaa T; Finckenberg P; Louhelainen M; Merasto S; Rauhala P; Lapatto R; Cheng ZJ; Reenilä I; Männistö P; Müller DN; Luft FC; Mervaala EM
J Hypertens; 2003 Dec; 21(12):2353-63. PubMed ID: 14654757
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure-independent effects in rats with human renin and angiotensinogen genes.
Mervaala E; Müller DN; Schmidt F; Park JK; Gross V; Bader M; Breu V; Ganten D; Haller H; Luft FC
Hypertension; 2000 Feb; 35(2):587-94. PubMed ID: 10679502
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats.
Theuer J; Dechend R; Muller DN; Park JK; Fiebeler A; Barta P; Ganten D; Haller H; Dietz R; Luft FC
BMC Cardiovasc Disord; 2002; 2():3. PubMed ID: 11835691
[TBL] [Abstract][Full Text] [Related]
16. Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage.
Muller DN; Mervaala EM; Schmidt F; Park JK; Dechend R; Genersch E; Breu V; Löffler BM; Ganten D; Schneider W; Haller H; Luft FC
Hypertension; 2000 Aug; 36(2):282-90. PubMed ID: 10948091
[TBL] [Abstract][Full Text] [Related]
17. The selective TP receptor antagonist, S18886 (terutroban), attenuates renal damage in the double transgenic rat model of hypertension.
Sebeková K; Ramuscak A; Boor P; Heidland A; Amann K
Am J Nephrol; 2008; 28(1):47-53. PubMed ID: 17890857
[TBL] [Abstract][Full Text] [Related]
18. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spironolactone and losartan regarding long-term blood pressure and target organ damage.
Baumann M; Hermans JJ; Janssen BJ; Peutz-Kootstra C; Witzke O; Heemann U; Smits JF; Boudier HA
J Hypertens; 2007 Dec; 25(12):2504-11. PubMed ID: 17984673
[TBL] [Abstract][Full Text] [Related]
19. Induction of cardiac fibrosis by aldosterone.
Lijnen P; Petrov V
J Mol Cell Cardiol; 2000 Jun; 32(6):865-79. PubMed ID: 10888242
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone.
Mulder P; Mellin V; Favre J; Vercauteren M; Remy-Jouet I; Monteil C; Richard V; Renet S; Henry JP; Jeng AY; Webb RL; Thuillez C
Eur Heart J; 2008 Sep; 29(17):2171-9. PubMed ID: 18586661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
